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1. Introduction 
Most proteinase inhibitors in blood plasma, e.g., 
antithromb~.III, Q i-antitrypsin, inter+trypsin inhib- 
itor, are specific towards serine proteinases and form 
1 :l complexes engaging the active site and thus com- 
pletely inhibiting the proteinase activity. a,-Macro- 
globulin is a tetrameric glycoprote~,~r 725 000, 
consisting of four app~ently identical chains. ‘Half- 
molecules’,Mr 360 000 can be obtained under non- 
reductive denaturing conditions [ 1,2]. Unlike the 
other inhibitors (YAM can form complexes with pro- 
teinases from different classes having different sub- 
strate specificities [3-51. furthermore, the active site 
of the complexed proteinase is accessible to smaller 
molecules as shown by the facts that the cr,M-trypsin 
can cleave synthetic substrates [6] and be inhibited 
by the bovine pancreatic trypsin inhibitor (Kunitz) 
(M, 6514) [7]. It. IS not accessible to larger protein 
substrates or ~hibitors, e.g., soy bean trypsin inhibi- 
tor, Mr 20 095 [?I. However, neither zymogens such 
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as prothrombin [8] or plasminogen [9], nor active- 
site-inhibited proteinases such as TLCK-trypsin [3] 
or Do-thromb~ [8] bind to a,M. This indicates 
that the complex formation involves a proteoiytic 
process [3]. Electron microscopy and gel electropho- 
resis indicate that the quaternary structure of oZM 
becomes more compact as a result of proteinase com- 
plex formation [ 5 ,I O-l 21. When incubating native 
crzM with different serine proteinases (trypsin, throm- 
bin, plasmin, plasma kallikrein or chymotrypsin) the 
Mr 180 000 subunits were cleaved near the middle of 
the polypeptide chain to produce 2 fragments of app. 
Mr 85 000 as seen in reducing SDS-PAGE [ 131. In 
fact binding to cr,M of proteinases from all 4 classes, 
namely serine, thiol, acid and metallo proteinases 
(EC 3 A .2 l-24) is accompanied by cleavage of the 
ol,M subunits to Mr 85 000 fragments [4]. Recent esti- 
mates indicate [ 1 l-l 61 that the a,M-proteinase 
complex contains a maximum of 2 mol proteinasel 
mol aaM. To provide a structural basis for describing 
the properties of QM its primary structure is cur- 
rently being investigated. Partial sequence results from 
these studies [ 171 indicate that the subunits of a,M 
are identical, each being composed of -1450 amino 
acid residues and having the C-terminal sequence: 
-Asx-Leu-Gly-Asx-Ala 
The same conclusion was reached [ 141 regarding the 
identity of the subunits of asM and the sequence of 
the N-terminal 13 residues was also reported [ 141. 
At present, 1383 residues from cu,M have been placed 
in three long, but not yet overlapped stretches and 
another -25-50 residues are known as sequences of 
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smaller peptides, in all accounting for -1408-1433 
residues (L. S., T.M. S., D. M. Rider, P. B. L., T. E. P., 
S. M., unpublished). Therefore, it appeared reason- 
able to assume that the site/s cleaved in cvzM during 
complex formation with proteinases could be identi- 
fied by comparing the results of direct sequence deter- 
mination of complexed and of noncomplexed CQM 
with the already known parts of the (YAM sequence. 
Apart from an N-terminal segment of non-com- 
plexed CQM this report describes the sequence of a 
35 residue internal stretch of ol,M which contains 
2 sites cleaved by elastase and 1 site cleaved by tryp- 
sin, plasmin and thrombin. 
2. Materials and methods 
Human a,M was prepared by Zn’+-affinity chro- 
matography as in [ 161. 
Human plasminogen was prepared by affinity chro- 
matography using Llysine Sepharose [ 181. Bovine 
thrombin prepared earlier [ 191 was used after storage 
at -20°C. Bovine TPCK-treated trypsin was from 
Worthington (Freehold NJ). Porcine pancreatic elas- 
tase was a gift from Dr D. Shotton (Cambridge). 
StaphyZococcus au~eus protease [20] was from Miles 
(Slough). Streptokinase (further purified before use 
[21]) was agift from Dr H. Nil&n (Kabi, Stockholm). 
Sepharose CL-4B and Sephadex G-25 were from Phar- 
macia (Uppsala). Benzamidine, PMSF, reagents for 
manual sequence analysis and standard chemicals 
were from Merck (Darmstadt) or from Fluka (Buchs). 
Manual sequence degradation was done [22] using 
heptane/ethyl acetate 2:l (v/v) [23] instead of ben- 
zene and using diethyl ether [24] to extract the ani- 
linothiazolinones from the dried peptide film or the 
partly dried protein film after having cleaved with 
TFA. PTH derivatives were determined by HPLC [25]. 
Sequenator analysis of proteinase-treated cr,M was 
performed in a Beckman 890C instrument and the 
resulting PTHs identified by HPLC and TLC [ 261. 
The peptides described were isolated from enzymic 
digests of CNBr-fragments from alM or of reduced, 
carboxymethylated a,M (citraconylated or not) by 
column chromatography and electrophoresis or chro- 
matography on paper [ 17,271. Amino acid composi- 
tions of peptides were determined after hydrolysis in 
6 M HCl, 0.1% phenol at 110°C for 16-24 h using a 
Beckman 121MB [28]. An Ei&nm = 9.1 [29] was 
used for cu,M. 
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3. Results 
Solutions of freeze-dried (YAM in 0.05 M Tris-HCI, 
0 .l M NaCl (pH 8 .O) clarified by centrifugation, con- 
tained 3.4-4.3 mg &,M/ml. Assuming that the tryp- 
sin, elastase and thrombin preparations contain 
50-60% active enzyme and streptokinase-activated 
plasminogen [2 l] 80% active plasmin, an amount of 
proteinase was added to 15-20 ml cu,M which would 
give a 2-fold molar excess of active enzyme over a,M. 
After incubating with trypsin for 1 min, plasmin for 
2 min or thrombin for 60 min, 1 M benzamidine was 
added to a final concentration of 50-60 mM. Elastase 
and cr,M were incubated for 1 min and then 0.1 M 
PMSF was added to 20 mM. Resulting ol,M-protein- 
ase complexes were precipitated by adding (NH&S04 
to 60% saturation and centrifuging, then redissolved 
in 6 M urea, 0.1 M NaCl, 0.5 M HCOOH (pH 2.9) and 
chromatographed as shown in fig.1 for cw,M-trypsin 
complex. 
Incubation of OVUM with trypsin or elastase as 
described above led to the almost complete cleavage 
of the 4 M, 180 000 subunits into M, 85 000 frag- 
ments as revealed by SDS-PAGE under reducing con- 
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Fig.1. Gel filtration of 5 1 mg or,M that had been incubated 
for 60 s with 5 mg TPCK-treated trypsin. The (NH,),SO, pre- 
cipitate was redissolved in 6 M urea, 0 .I M NaCl, 0.5 M 
HCOOH (pH 2.9) and applied to a column (2.5 X 90 cm) of 
Sepharose CL4B, equilibrated and eluted with the same buff- 
er at a flow rate of 20 ml/h (5 ml fractions). The effluent was 
collected in 2 pools (1,2) as indicated. After desalting on a 
kolumn (5 X 20 cm) of Sephadex G-25 in 0.1 M HCOOH, the 
solutions were freezedried. Both pools 1,2, together consti- 
tuting the irregular main peak (A), fractions 59-82, were 
found to contain ol,M half-molecules (Mr 360 000) and aggre- 
gates complexed with trypsin. The small peak (B) frac- 
tions83-92,probably containfreetrypsin.Onanabsorbance 
basis it would correspond to 15% of the added trypsin. The 
peak at fractions 100-l 10 contained residual benzamidine. 
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10 20 
Ser-Val-Ser-Gly-Lys-Pro-Gln-Tyr-Met-Val-Leu-Va~-Pro-Ser-Leu-Leu-His-Thr-Glu-Thr-Thr-Glu-Lys-(53 res.)-Met- 
Fjg.2. Amino acid sequence of residues 1-23 of human cu,M. Peptide nomenclature: CB-A, CB-B, CNBr-fragments; Tl, tryptic 
peptide from reduced,carboxymethy~ted oc,M. Solid lines correspond to amino acid compositions, half arrows to manual sequence 
results. 
ditions. However, the extent of cleavage by plasmin 
or thrombin was only -50%. 
The separation patterns obtained for cr,M incu- 
bated with the other 3 proteinases were very similar 
to that shown in fig.1. In particular, the amount of 
material eluting in the corresponding peak B could 
account for only 10-l 5% of the added amount of 
proteinase, indicating that the complexed proteinases 
remained bound to cu,M even under these strongly 
denatu~g conditions. 
Direct manual sequence determination through 
6 steps of human a,M gave the sequence: 
Ser-Val-Ser-Gly-Lys-Pro- (fig.2) 
From this, and the structures of Tl , CB-A and CB-B, 
the sequence of the first 23 residues of cu,M was d.eter- 
mined (fig.2). These results agree with and extend 
data [ 141 on residues l-1 3 of cu,M. Both cwzM-tryp 
sin and cr,M-elastase yielded a mixed sequence with 
two major residues released in each cycle of Edman 
degradation, one from the original N-terminus of a,M 
(common to both sets of data) and one from the 
cleavage site in (u2M (tables 1,2). These two major 
sequences could be discriminated confidently through 
12 steps using the sequenator procedure (tables 1,2). 
Table 1 
Majora N-terminal sequences of prote~ase-treated a,M 
Position Known sequences 
(f&.2,3) 
Residues detected (nmoDb after proteolytic cleavage 
of a,M with 
1 Leu 
2 Val 
3 His 
4 Val 
5 Glu 
6 Glu 
7 Pro 
8 His 
9 Thr 
10 Glu 
11 Thr 
12 Val 
New 
N-terminal 
Original 
N-terminal 
Trypsin Plasmin Thrombin 
Ser 
Vat 
Ser 
GLY 
LYS 
Pro 
Gin 
Tyr 
Met 
Val 
Leu 
Val 
Leu(25) Ser(>lO) 
Val(50) 
His(20) Ser(>lO) 
Val(25) Gly(>lO) 
Glu(>lO) Lys(rl0) 
Glu(>lO) Pro(>lOf 
Pro(20) Gln(15) 
His(l0) Tyr(lS) 
Thr(l0) Met(l0) 
(Glu) (Val) 
(Thr) (Leu) 
Wal) 
(Leu) (Ser) (Leu) (Ser) 
(Val) Wall 
(Ser) _ 69x1 
Cval) (Gly) 
(Glu) (LY s) KM GY s) 
(Glu) (Pro) (Glu) - 
(Pro) (Gin) _ (Gin) 
- (TY r) - (Tyr) 
(Thr) (Met) - (Met) 
a Additional background could be interpreted as being derived from the known N-terminal sequences 
of the respective proteinase as discussed in the text 
b PTH amino acids were analysed and quantitated by HPLC 
Positionsnot properly identified are shownby dashes.Two preparationsofol,M-trypsin complex were 
analysed with similar results, using material from pools 1 and 2 (fig.1). About 10 nmol was used for 
each degradation. One preparation each of cr,M-plasmin and cY,M-thrombin complex, respectively, 
(pools 1 + 2 material, 12 nmol) were analysed with similar results (not quantitated). Brackets indicate 
residues ident~ied but not quantitated 
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Table 2 
Majora N-terminal sequences of elastase-treated cu,M 
Position Known sequences 
(fig.23) 
New Original 
N-terminal N-terminal 
Residues detected (nmoQb after 
proteolytic cleavage of cu,M with 
elastase 
1 GlY 
2 Phe 
3 Tyr 
4 GlU 
5 Ser 
6 Asp 
7 Val 
8 Met 
9 Gly 
10 Arg 
11 GlY 
12 His 
Ser 
Val 
Ser 
GlY 
LYS 
Pro 
Gin 
Tyr 
Met 
Val 
Leu 
Val 
Gly(>lO) Phe(>lO) Ser(> 10) 
Phe(20) Tyrf<lO) Val(20) 
Tyr(l5) Ser(>lO) 
Glu(>lO) Gly(>lO) 
Ser(<lO) LY SW9 
-_ 
Val(l0) 
Met(l0) 
GlY(LO) 
- 
(Gly) 
- 
Gln(I0) 
Tyr(i5) 
Met(l5) 
tv’al) 
(Leu) 
(Val) 
a Additional background could be interpreted as being derived from the known 
N-terminal sequence of elastase 
b PTH ammo acids were analysed and quantitated by HPLC 
Positions not properly identified are shown by dashes; 10 nmoi of pools 1 and 2 
material from one preparation of CQ M-elastase complex was degraded with similar 
results. Brackets indicate residues identified but not quantitated 
T,Pl,Th 
, CB;PT141CB-,P~2, , ;, CB-PT3 
fIrtrfIII,j 
Fig.3. Ammo acid sequence of a 35 residue stretch from the middle of the or,M subunits containing the cleavage sites for trypsin 
(plasmin, thrombin) and for elastase, respectively. Peptide nomenclature: CBC) and CB-P, CNBr fragments from u,M; T2, tryptic 
peptide from reduced, carboxymethylated, citraconylated 02M; CBPTl3, tryptic peptides from CBP; CBPSPl, peptide from 
maleylated CBP obtained after digestion with a protease from Staphylococcus aureus strain V8; CBPCl-2 chymotryptic peptides 
from CB-P. Because its N-terminal was blocked the sequence of CBPSPl was deduced from the sequences of its three tryptic sub- 
peptides corresponding to CB-PTd-2 and residues l-10 of CB-PT3: (1) the cleavage site for trypsin (plasmin, thrombin) and the 
major cleavage site for elastase; (4) minor cleavage site for elastase; T, trypsin; PI, Plasmin; Th, thrombin; E, elastase. 
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The new N-terminal sequence revealed at the tryp- 
sin cleavage site was deduced as: 
mu-Val-us-Val-Glu-Glu-do-us-or- 
Glu-Th-Val- 
The new N-terminal sequence deduced for the elastase 
cleavage site was: 
Gly-Phe-Tyr-Glu-Ser-X-Val-Met-Gly-X- 
Gly-X 
The results (table 2) also indicate the presence of an 
additional minor new N-terminal cu,M-sequence in the 
a,M-elastase, namely Phe-Tyr-. By manual sequence 
determination, however, 4 residues of the latter 
sequence could be deduced extending it to: 
Phe-Tyr-Glu-Ser- 
The 3 sequences thus identi~ed form part of a 298 
residue stretch in the part ofcu,M already sequenced. 
Fig.3 shows the relative positions of these cleavage 
sites in a 35 residue segment of this 298 residue stretch. 
The sequence of this segment had been deduced by 
combining data from amino acid analysis (table 3) 
and manual sequence determination. The minimal evi- 
dence required to prove the sequence is presented in 
fig.3 (redundant ~formation not included). Despite 
the fact that plasmin and thrombin cleaved cuzM only 
to -50% the characteristic sequence: 
Leu-Val-X-X-Glu-Glu (table 1) 
could be identified in both cases. Thus, thrombin and 
plasmin cleaved at the same site as trypsin in the 
‘bait’ region. 
In addition to the major sequences derived from 
a,M itself part of the known N-terminal sequence of 
the proteinase, namely Ile-1 , Gly-3, Tyr-5, Ala-9 of 
trypsin in a yield of 0.3 mollmol a,M-subunit and 
Val-I , Gly-3, Ala-7, Asn-10 of elastase in a yield of 
0.25 mollmol orzM-subunit, was recognized as ‘back- 
ground’. In o_,M-thrombin Glu-3 and Ala-7 from the 
enzyme and in azM-plasmin Val-1 , Gly-3, Val-6 and 
Ala-7 were recognized in lower yield. 
Table 3 
Amino acid composition, yields and electrophoretic mobilities of peptides used for deducing the sequences of the two stretches 
from a,M shown in fig.2,3a 
CB-A CB-B Tl T2 CBO CB-PTl CB-PT2 CB-PT3 CB-PSPl CBPC1 CB-PC2 
CmCys 
Asx 
Thr 
Ser 
Ghi 
Pro 
Gf Y 
Afa 
Val 
Metd 
He 
GlcN 
Leu 
Tyr 
Phe 
Lys 
His 
Arg 
1.6 (2) 
6.0 (6) 1.0(l) 1.0(l) 
5.6 (6) 2.9(3) 2.0(2) 0.8(l) 
1.8(2) 7.7 (8) 2.7(3) 0.8(l) 0.8(l) 
1*0(l) 8.7 (8) 3.2(3) 1.0(l) 2.3(2) 3.1(3) U?(3) 
0.9(l) 2.3 (2) 2.1(2) IS(l) 1*1(l) 1.0(l) 
U(l) 2.3 (2) L!J(l) 1.8(2) U(3) l&l) I&l) I .8(2) U?(2) 
4.2 (4) 09(l) 0.8(l) 1*0(l) 
1.2(l) ll.O(lO) 3.3(3) 1.9(2) 2.3(2) 3.1(3) 1.9(2) 
f (1) + (1) 0.90) 0.8(l) + (1) 
l+o.2(10) 3.1(3) I.&W 1.1(l) U(l) 
1.1(l) 1.0 (1) 1*0(l) 1*2(l) 03(L) 
2.2 (2) 1.2(l) 09(l) 
1.0(l) 2.2 (2) 2.0(2) O&O)” 
1.9 (2) 1.0(l) 0.9(l) 1.0(l) 2.0(2) 2.6(3) 1.0(l) 
2,o (2) U(l) 0.9(l) 1.0(l) 1.0(l) 1.0(l) 2.1(2) 0.9(l) 1.0(l) 
Yield %) 10 
6 
30 12 15 16 10 15 25 14 
m6.5 -0.27 -0.06 -0.23 0.35 -0.77 -0.68 0 of -50.68 z.73 
m 1.9c 095 0.95 0.84 0.92 1.32 
a The compositions are listed as molar ratios with the residue used as a basis for the calculation underlined. The number of residues 
expected from the sequence analysis is listed in brackets. The values are not corrected for incomplete hydrolysis losses 
b Electrophoretic mobility relative to aspartic acid at pH 65; c Electrophoretic mobility relative to serine at pH 1.9; d Homoserine 
and homoserine lactone in CNBr fragments were not quantitated, . e CB-PTl was contaminated with free lysine; f CBPSPl was 
~bamy~ted 
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4. Discussion [33,34] in the identical heptapeptide sequences: 
Assuming an initial coupling yield of 60% the 
N-terminal sequence of cr2M was recovered in a yield 
compatible with oZM being composed of 4 identical 
subunits of Mr 180 000 [ 14,171. 
Moreover, the yield of the additional N-terminal 
sequence exposed as a result of the specific cleavage 
by trypsin or elastase during their complex formation 
with (Y*M was essentially the same as that obtained 
for the original N-terminal sequence, showing that the 
sequences of all 4 subunits are identical in this region, 
and also that complete cleavage of all 4 subunits had 
occurred at closely spaced sites in the ‘bait’ region. 
Trypsin, plasmin and thrombin were found to cleave 
at the same Arg-Leu bond (fig.3). Whether additional 
cleavage had occurred at the Arg-Val and Arg-Gly 
bonds located 4 and 15 residues before the Arg-Leu 
bond is not known, since the resulting small peptides 
would have escaped detection in the present experi- 
ments. Elastase was found to cleave arzM in 2 other 
places, a major cleavage at the Val-Gly bound and a 
minor cleavage at the following Gly-Phe bond in the 
‘bait’ region sequence (fig.3). The 2 elastase-cleavage 
sites are located 13 and 14 residues before the com- 
mon trypsin-plasmin-thrombin cleavage site, show- 
ing that the bait region comprises at least 15 residues. 
Although it is not known whether cleavage of any 
peptide bond within the bait region will lead to forma- 
tion of a,M-proteinase complexes, these data show 
that cleavage of (Y*M by the proteinases investigated 
reflects their primary substrate specificity. This indi- 
cates that only those protemases which can cleave (a) 
specific bond(s) within the ban region can form a 
complex with (YAM. The trypsin/thrombin/plasmin 
cleavage site is located -665-700 residues from the 
N-terminal. 
-Gly-Cys-Gly-Glu-Glx-Asn-Met- 
in the 2proteins [33,34,36]. The Glx-residue islocated 
-256 residues after the tryptic cleavage site in the bait 
region. Upon activation of apM by trypsin or pan- 
creatic elastase [ 161 and of C3 with trypsin [34,35] 
their thiol ester group/s is/are rapidly cleaved resulting 
in the appearance of SH-groups [ 16,34,35]. On the 
basis of these results it has been suggested that crZM 
and C3, when activated, participate in ‘acyl-transfer’ 
reactions, leading to the formation of covalent bonds 
between a,M and proteinase [ 161 or between C3 and 
specific cell-surface structures [34,35]. Because the 
‘bait’region cleavage reflects the specificity of the pro- 
teinase the ‘initial’ azM-proteinase complex must 
involve the active site of the proteinase binding to the 
‘bait’ region of oZM. Because the ‘final’ complex, which 
presumably involves the thiol-esterified Glx of cu,M 
[16], is active against small substrates for the protein- 
ase it cannot involve the active site of the proteinase. 
Thus, azM-proteinase complex formation occurs in 
at least 2 structurally well-defined steps. The ‘final’ 
complex is rapidly removed from the circulation [37], 
being taken up by cells, e.g., macrophages and fibro- 
blasts [38&40]. Therefore, the formation of cuzM- 
proteinase complexes following cleavage of a single 
peptide bond in the ‘bait’ region can now be recog- 
nized as another example of a physiological process 
activated by specific limited proteolysis. Because bait- 
region cleavage in oZM and anaphylatoxin release from 
C3 and C5 now seem to play corresponding roles in 
the ‘activation’ of these proteins the sequence preced- 
ing the cleavage sites in the bait region of cr,M was 
prateinase cleavage site 
The stability of azM-proteinase complexes during 
SDS-PAGE under reducing conditions suggests that 
the proteinase binds covalently to oZM [30-321. This 
conclusion is supported by earlier results [ I.51 and 
the present finding, that most of the proteinase is not 
released from cu,M-proteinase complexes during gel 
filtration under denaturing conditions (fig.1). Further- 
more the N-terminal sequences of the proteinases 
were recognized in the ozM-complexes. The 4 chains 
of o,M [ 16,331 and the cr’chain part of complement 
component C3 [34,3.5 ] both contain an internal reac- 
tive thiol ester, involving the y-carboxyl group of the 
Glxqesidue and the thiol group of the Cys-residue 
C5a (human) LJ---ANISHKDMQCGR 1 
C3a (human) -i LRRQHARASH--LGLAR -- 
C3a (pig) LRQQHSRNKP--LGLAR 1 
c3a (rat) LJEOHRRDHV--LGLAR 
a2Ma (human) 
a,Mb (human) 
Fig.4. Sequence similarities found by comparing the total 
sequences of anaphylatoxins C3a and C5a with the 80add 
residue sequence of a,M preceding the bait region cleavage 
sites for trypsin/thrombin/plasmti and for elastase. Identities 
between the complement components on the one hand and 
one of the cY,M-sites on the other are underlined. Mutually 
identical residues between the 2 a,M-sites are boxed. a (Ye M, 
the trypsin,thrombin,plasmincleavagesite;b a*M,themajor 
elastase-cleavage site. 
172 
Volume 127, number 2 FEBS LETTERS May 1981 
compared with the mutually homologous sequences of 
C3a and CSa f4 I ] by visual inspection. The sequence 
similarities found in the last 14-I 7 residues before 
the cleavage sites (fig.4) may be the result of analo- 
gous/homologous evolution of these parts of a,M and 
the 2 complement components. 
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